San Ramon, California-based The Cooper Companies, Inc. (COO) develops, manufactures, and markets contact lenses for wearers. The company has a market cap of $10.5 billion and operates in two segments, CooperVision and CooperSurgical, and offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia, and more. COO is expected to release its Q4 2026 earnings soon.
Ahead of the event, analysts expect the company’s EPS to be $1.07 on a diluted basis, down 7% from $1.15 in the year-ago quarter. The company has exceeded Wall Street’s EPS estimates in each of its last four quarters, which is impressive.
More Top Stocks Daily: Go behind Wall Street’s hottest headlines with Barchart’s Active Investor newsletter.
For fiscal 2026, analysts project the company’s EPS to be $4.53, up 10% from $4.12 in fiscal 2025. Moreover, its EPS is expected to rise by roughly 3.5% year over year (YoY) to $4.69 in fiscal 2027.
www.barchart.comCOO stock has declined 17.2% over the past 52 weeks, underperforming the S&P 500 Index’s ($SPX) 12.4% rise and the State Street Healthcare Select Sector SPDR ETF’s (XLV) 23.6% rise during the same time frame.
www.barchart.comAnalysts are not too excited about COO stock due to a couple of reasons tied to the company’s performance. COO’s annual sales growth over the past two years has been nearly 6.5%, below the industry average for healthcare companies. Additionally, its sales growth is estimated to be 4.2% for the next year, indicating tepid demand, even lower than the last two years. Its returns on capital are also below average, indicating a lack of compelling investment opportunities by management.
Analysts are neutral on COO, with the stock having a “Hold” rating overall. Among the 18 analysts covering the stock, four are recommending a “Strong Buy,” one suggests a “Moderate Buy,” 11 recommend a “Hold,” and two suggest a “Strong Sell.” COO’s average analyst price target of $65.25 indicates a 9.8% upside from current levels.
On the date of publication, Aritra Gangopadhyay did not directly have a position in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.
More news from Barchart
Dear Shell Stock Fans, Mark Your Calendars for October 29 This Financial Stock Just Raised Its Dividend by 17% Dear AMD Stock Fans, Mark Your Calendar for November 3 Pokémon Go Was Supposed to Bring People Together. Instead, It Trained AI for Military Drones.